Extrinsic stabilization of antiviral ACE2-Fc fusion proteins targeting SARS-CoV-2

7Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The angiotensin-converting enzyme 2 (ACE2) is a viral receptor used by sarbecoviruses to infect cells. Fusion proteins comprising extracellular ACE2 domains and the Fc part of immunoglobulins exhibit high virus neutralization efficiency, but the structure and stability of these molecules are poorly understood. We show that although the hinge between the ACE2 and the IgG4-Fc is highly flexible, the conformational dynamics of the two ACE2 domains is restricted by their association. Interestingly, the conformational stability of the ACE2 moiety is much lower than that of the Fc part. We found that chemical compounds binding to ACE2, such as DX600 and MLN4760, can be used to strongly increase the thermal stability of the ACE2 by different mechanisms. Together, our findings reveal a general concept for stabilizing the labile receptor segments of therapeutic antiviral fusion proteins by chemical compounds.

Cite

CITATION STYLE

APA

Svilenov, H. L., Delhommel, F., Siebenmorgen, T., Rührnößl, F., Popowicz, G. M., Reiter, A., … Buchner, J. (2023). Extrinsic stabilization of antiviral ACE2-Fc fusion proteins targeting SARS-CoV-2. Communications Biology, 6(1). https://doi.org/10.1038/s42003-023-04762-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free